Items Tagged ‘HER-2’

November 1st, 2017

Nerlynx Modestly Improves Survival of HER 2-Positive Early Stage Breast Cancer

By

Positive results from the clinical trial evaluating neratinib for the extended adjuvant treatment of early stage HER2-positive breast cancer following trastuzumab-based therapy (ExteNET trial) were presented at the European Society of Medical Oncology (ESMO) 2017 Congress in Madrid, Spain. About HER2-Positive Breast Cancer Approximately 20% to 25% of breast cancers over-express the HER2 protein. HER2-positive […]

View full entry

Tags: Breast Cancer, HER-2, HER4 Positive Early Stage Breast Cancer, herceptin, Nerlynx HER1, News, Precision Cancer Medicine, trastuzumab


September 9th, 2014

New Guidelines on Treatment of HER2-Negative Breast Cancer Aim to Improve Patient Outcomes

By

The American Society of Clinical Oncology (ASCO) recently released updated guidelines for the treatment of advanced HER2-negative breast cancer. The Journal of Clinical Oncology will publish the new guidelines, which include hormone therapy and sequential chemotherapy.[1] One of the ways breast cancers are classified is according to HER2 status, a measure of the amount of the HER2 […]

View full entry

Tags: Breast Cancer, HER-2, Metastatic Breast Cancer, News, Recurrent Breast Cancer